IP Library Granted Patent US 9,238,010
Granted Patent B2
US 9,238,010 · App. 13/976,796 · Granted Jan 19, 2016

Vesicles and nanostructures from recombinant proteins

Inventors: Daniel A. Hammer (Villanova, PA); Kevin Vargo (Philadelphia, PA); Ranganath Parthasarathy (Glenmoore, PA)
Assignee: The Trustees of the University of Pennsylvania
A61K9/5169A61K9/1272A61K9/1273A61K31/7088A61K38/00A61K38/168A61K45/06A61K47/488A61K51/1251
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,010
App. No.
13/976,796
Granted
Jan 19, 2016
Kind
B2
Abstract

The present invention includes a composition comprising at least one oleosin-like protein. The present invention also includes a composition comprising a vesicle comprising at least one oleosin-like protein.

Claims (13)

1. A composition comprising a protein comprising a sequence that has at least 80% homology to an oleosin-like protein selected from the group consisting of SEQ ID NOs:21-26, and combinations thereof, wherein said protein is capable of self-assembling into a polypeptide vesicle.

2. The composition of claim 1 , wherein said sequence has at least 90% homology to an oleosin-like protein selected from the group consisting of SEQ ID NOs:21-26, and combinations thereof.

3. The composition of claim 2 , wherein said sequence has at least 95% homology to an oleosin-like protein selected from the group consisting of SEQ ID NOs:21-26, and combinations thereof.

4. The composition of claim 1 , wherein a receptor binding motif is attached to the N-terminus or the C-terminus of said sequence via an amide bond.

5. The composition of claim 4 , wherein said motif is selected from the group consisting of SEQ ID NOs:4-6.

6. The composition of claim 1 , wherein at least two residues of said oleosin-like protein are replaced with cysteine residues.

7. The composition of claim 1 , wherein at least one tyrosine residue in said oleosin-like protein is converted to a L-DOPA residue via a chemical reaction.

8. The composition of claim 7 , wherein at least two of said L-DOPA residues are further crosslinked via a chemical reaction.

9. The composition of claim 1 , wherein at least one sequence selected from the group consisting of SEQ ID NOs:8-12 is inserted in said oleosin-like protein (i) at the junction of hydrophilic and hydrophobic segments, or (ii) within the hydrophilic segment.

10. A composition comprising a vesicle, wherein said vesicle comprises a protein comprising a sequence that has at least 80% homology to an oleosin-like protein selected from the group consisting of SEQ ID NOs:21-26, and combinations thereof.

11. The composition of claim 10 , further comprising a compound encapsulated within said vesicle, wherein said compound is selected from the group consisting of a gas, drug, fluorescent dye, radioactive probe, salt, protein, and nucleic acid.

12. The composition of claim 10 , further comprising at least one pharmaceutically acceptable carrier.

13. A composition comprising a protein comprising a peptide sequence as set forth in residues 26-88 of SEQ ID NO:21, wherein said protein is capable of self-assembling into a polypeptide vesicle.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 18, 2015
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 037145/0997 →
Continuity (2)
Provisional Application 61432476 · Jan 13, 2011
Related Publication 20140105818A1 · Apr 17, 2014